Phase 1 Corneal Endothelial Dystrophy Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Simple Non-cultured Endothelial Cell Therapy for Corneal Endothelial Dysfunction

Bullous KeratopathyCorneal Endothelial Dystrophy

Singapore Eye Research Institute20 enrolled1 locationNCT07711561

Recruiting

Phase 1

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

Endothelial DysfunctionPseudophakic Bullous KeratopathyFuchs' Endothelial Dystrophy+5 more

Asociación para Evitar la Ceguera en México12 enrolled1 locationNCT05636579